Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care

BACKGROUND: Newly approved, drug-modifying therapies are associated with still unknown adverse events, although clinical trials leading to approval have strict inclusion and exclusion criteria and analyse safety and efficacy. OBJECTIVES: The aim of this study was to analyse the eligibility of multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Jalusic, Kris Oliver, Ellenberger, David, Rommer, Paulus, Stahmann, Alexander, Zettl, Uwe, Berger, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521377/
https://www.ncbi.nlm.nih.gov/pubmed/33467978
http://dx.doi.org/10.1177/1352458520985118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521377/
https://www.ncbi.nlm.nih.gov/pubmed/33467978
http://dx.doi.org/10.1177/1352458520985118

Ejemplares similares